TABLE 1.
Baseline clinical characteristics between the ND group and LCD group
| Parametersa | ND (n = 25)b | LCD (n = 26)b | P valuec |
|---|---|---|---|
| Female/male | 16/9 | 22/4 | |
| Age, yrs | 35.80 (±8.27) | 36.58 (±8.70) | 0.745 |
| BMI, kg m−2 | 28.61 (±2.04) | 30.44 (±3.38) | 0.024d |
| BMR, kcal | 1,497.41 (±202.64) | 1,494.70 (±172.32) | 0.959 |
| Waist, cm | 90.98 (±8.22) | 94.28 (±9.69) | 0.196 |
| WHR, ratio | 0.87 (±0.05) | 0.90 (±0.05) | 0.046d |
| BFR, % | 33.18 (±4.16) | 36.53 (±5.10) | 0.013d |
| VFA, cm2 | 104.90 (±25.98） | 122.00 (±37.60) | 0.056 |
| LBM, kg | 50.17 (±9.97) | 50.38 (±8.39) | 0.936 |
| FPG, mg dl−1 | 92.61 (±10.39) | 90.95 (±9.10) | 0.378 |
| HOMA-IR | 4.14 (±3.56) | 3.58 (±1.75) | 0.492 |
| Insulin, mIU liter−1 | 16.29 (±13.91) | 15.91 (±7.45) | 0.904 |
| TG, mg dl−1 | 138.62 (±89.42) | 111.75 (±30.84) | 0.176 |
| T_Chol, mg dl−1 | 189.59 (±40.46) | 185.62 (±29.53) | 0.699 |
| HDL-C, mg dl−1 | 47.32 (±8.27) | 48.91 (±12.11) | 0.435 |
| LDL-C, mg dl−1 | 116.96 (±35.61) | 115.78 (±25.55) | 0.878 |
| ALT, IU liter−1 | 24.64 (±21.22) | 22.00 (±10.28) | 0.581 |
| AST, IU liter−1 | 20.51 (±10.11) | 19.46 (±7.80) | 0.688 |
| Urea, mg dl−1 | 13.46 (±2.05) | 13.23 (±3.09) | 0.757 |
| Cr, mg dl−1 | 0.79 (±0.21) | 0.77 (±0.14) | 0.615 |
| UA, mg dl−1 | 6.54 (±1.72) | 6.23 (±1.76) | 0.179 |
a
BMI, body mass index; BMR, basal metabolic rate; WHR, waist-to-hip ratio; BFR, body fat ratio; VFA, visceral fat area; LBM, lean body mass; FPG, fasting plasma glucose; HOMA-IR, homeostasis model assessment-insulin resistance index; TG, triglyceride; T_Chol, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Cr, creatinine; UA, uric acid.
b
Data are expressed as mean ± SD.
c
P values were determined by independent Student’s t test.
d
P value less than 0.05.